Is SCNLF or RYLD a better dividend investment in 2026?

SCNLF currently yields 1373.63% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: SCNLF offers higher current income.

What is the dividend yield difference between SCNLF and RYLD?

SCNLF has a forward dividend yield of 1373.63% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 1361.49 percentage points.

Home › Compare › SCNLF vs RYLD

SCNLF vs RYLD: Dividend Comparison 2026

SCNLF yields 1373.63% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCNLF wins by $315919182.74M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCNLF

● Live price

1373.63%

Share price

$0.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$315919182.78M

Annual income

$276,344,297,604,930.75

Full SCNLF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — SCNLF vs RYLD

📍 SCNLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCNLF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCNLF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCNLF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCNLF

Annual income on $10K today (after 15% tax)

$116,758.24/yr

After 10yr DRIP, annual income (after tax)

$234,892,652,964,191.12/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, SCNLF beats the other by $234,892,652,961,991.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCNLF + RYLD for your $10,000?

SCNLF: 50%RYLD: 50%

100% RYLD50/50100% SCNLF

Portfolio after 10yr

$157959591.41M

Annual income

$138,172,148,803,759.05/yr

Blended yield

87.47%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCNLF buys

RYLD buys

No recent congressional trades found for SCNLF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCNLFRYLD

Forward yield	1373.63% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$315919182.78M ✓	$44.5K
Annual income after 10y	$276,344,297,604,930.75 ✓	$2,587.35
Total dividends collected	$313011682.66M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SCNLF vs RYLD ($10,000, DRIP)

Year	SCNLF Portfolio	SCNLF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$148,063	$137,362.64	$11,914	$1,213.65	+$136.1K → SCNLF
2	$2,059,200	$1,900,773.30	$14,099	$1,351.30	+$2.05M → SCNLF
3	$26,909,187	$24,705,842.24	$16,580	$1,494.55	+$26.89M → SCNLF
4	$330,522,388	$301,729,558.78	$19,384	$1,642.61	+$330.50M → SCNLF
5	$3,817,312,082	$3,463,653,126.46	$22,535	$1,794.70	+$3817.29M → SCNLF
6	$41,470,385,979	$37,385,862,050.80	$26,063	$1,950.00	+$41470.36M → SCNLF
7	$423,953,934,089	$379,580,621,092.34	$29,995	$2,107.69	+$423953.90M → SCNLF
8	$4,080,240,641,140	$3,626,609,931,664.44	$34,361	$2,266.99	+$4080240.61M → SCNLF
9	$36,985,873,996,458	$32,620,016,510,437.74	$39,194	$2,427.12	+$36985873.96M → SCNLF
10	$315,919,182,781,141	$276,344,297,604,930.75	$44,525	$2,587.35	+$315919182.74M → SCNLF

SCNLF vs RYLD: Complete Analysis 2026

SCNLF — Stock

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

Full SCNLF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this SCNLF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCNLF vs SCHD SCNLF vs JEPI SCNLF vs O SCNLF vs KO SCNLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.